mirtazapine has been researched along with Epistaxis in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Epistaxis: Bleeding from the nose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mirza, T | 1 |
| Majeed, MH | 1 |
| Benazzi, F | 1 |
2 other studies available for mirtazapine and Epistaxis
| Article | Year |
|---|---|
Mirtazapine-Induced Epistaxis in an Australian Indigenous Man.
Topics: Adolescent; Australia; Depressive Disorder, Major; Epistaxis; Humans; Male; Mirtazapine; Native Hawa | 2018 |
Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dos | 2005 |